Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
IFRX similar filings
- 21 Jun 23 InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
- 11 May 23 Current report (foreign)
- 27 Apr 23 Current report (foreign)
- 13 Apr 23 Current report (foreign)
- 5 Apr 23 Current report (foreign)
- 4 Apr 23 InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
- 22 Mar 23 InflaRx Reports Full Year 2022 Financial and Operating Results
Filing view
External links